NRX Pharmaceuticals, Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate for 2023.
  • NRX Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $374K.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $885K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.